Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[FGF23 and bone metabolism].

Nobuaki Ito1, Seiji Fukumoto

  • 1Division of Nephrology and Endcrinology, Department of Internal Medicine, University of Tokyo.

Clinical Calcium
|July 5, 2005
PubMed
Summary

Fibroblast growth factor (FGF) 23 regulates serum phosphate and vitamin D levels. FGF23 is implicated in diseases like rickets and osteomalacia, highlighting its crucial physiological role.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrated Genetic and Biochemical Approach to Patients with Bone Disorders Exhibiting Low Alkaline Phosphatase.

Calcified tissue international·2026
Same author

Tumor-induced osteomalacia: a 2026 update.

Minerva medica·2026
Same author

Real-world Impact of Treatment on Growth in Children With X-Linked Hypophosphatemia.

The Journal of clinical endocrinology and metabolism·2026
Same author

Autoimmune osteomalacia: a novel FGF23-related hypophosphatemic osteomalacia.

Journal of bone and mineral metabolism·2026
Same author

Incidence and clinical significance of inducible perimitral atrial tachycardia in patients with atrial fibrillation.

Heart and vessels·2026
Same author

The prevalence of ENPP1 deficiency in humans with Ossification of the Posterior Longitudinal Ligament and the preclinical efficacy of ENPP1 enzyme therapy in murine Ossification of the Posterior Longitudinal Ligament.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2025

Area of Science:

  • Endocrinology
  • Mineral Metabolism
  • Genetics

Background:

  • Fibroblast growth factor (FGF) 23 impacts serum phosphate and active vitamin D production, independent of parathyroid hormone.
  • FGF23 is linked to various diseases, including autosomal dominant hypophosphatemic rickets/osteomalacia (ADHR), X-linked hypophosphatemic rickets/osteomalacia (XLH), and tumor-induced rickets/osteomalacia (TIO).

Purpose of the Study:

  • To elucidate the physiological role of FGF23 in phosphate regulation.
  • To understand FGF23's involvement in hypophosphatemic rickets and osteomalacia.

Main Methods:

  • Review of existing literature on FGF23.
  • Analysis of FGF23 null mouse models exhibiting altered phosphate levels.

Main Results:

  • FGF23 modulates renal tubular phosphate reabsorption.
  • FGF23 influences the production of active vitamin D.
  • FGF23 null mice exhibit hyperphosphatemia, suggesting a physiological role in phosphate homeostasis.

Conclusions:

  • FGF23 is a key regulator of phosphate and vitamin D metabolism.
  • Dysregulation of FGF23 contributes to hypophosphatemic bone diseases.
  • Further research into FGF23 pathways is crucial for understanding and treating related disorders.

Related Experiment Videos